- £1.23bn
- £1.28bn
- £2.01bn
- 83
- 52
- 40
- 61
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,654 | 1,305 | 1,644 | 1,990 | 2,010 |
Cost of Revenue | |||||
Gross Profit | 855 | 610 | 878 | 1,076 | 1,007 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Total Operating Expenses | 1,507 | 1,288 | 1,475 | 1,794 | 1,891 |
Operating Profit | 147 | 17 | 169 | 196 | 119 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 144 | 15.5 | 167 | 194 | 117 |
Provision for Income Taxes | |||||
Net Income After Taxes | 103 | -5.74 | 118 | 139 | 77.1 |
Net Income Before Extraordinary Items | |||||
Net Income | 103 | -5.74 | 118 | 139 | 77.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 103 | -5.74 | 118 | 139 | 77.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.322 | -0.017 | 0.37 | 0.445 | 0.267 |
Dividends per Share | |||||
Special Dividends per Share |